Mds Podcast

Perampanel may reduce alpha-synuclein transmission in Parkinson's disease. A possible therapeutic target? 

Informações:

Sinopse

Dr. Matarazzo speaks with Prof. Takahashi about the results of his recent study that shows how this anti-epileptic drug may inhibit the transmission of alpha synuclein in PD. While this was tested in animal models, future clinical trials are warranted to test the effects on PD progression.